Acute graft-versus-host disease (aGVHD) is one of the most serious complications after allogeneic hematopoietic stem cell ...
New Phase 2a data show the oral IPF therapy GRI-0621 modulates immune cell activity in adults with idiopathic pulmonary ...
Eureka Therapeutics, Inc., a clinical-stage biotechnology company advancing next-generation T-cell therapies for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules.
Trump’s remarks, delivered over the past two days, have set the tone for a wider escalation, as governments from Mexico to Greenland, as well as Cuba and Iran, have reacted with alarm, rejection or ...
Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response to cancer in mice—effectively ...
Exclusive collaboration and license agreement focuses on advancing novel T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the CUE-100 series of Immuno-STATs® Novel therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results